Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantationJana Sawyer, Kendall C. Shultes, Taylor Elliott et al.|Clinical Hematology International|2024Cited by 9
Impact of Granulocyte Colony Stimulating Factor Use Following CD-19 Chimeric Antigen Receptor T-Cell TherapyMarshall Winget, Lindsay Orton, Reena Jayani et al.|Transplantation and Cellular Therapy|2025Cited by 3
Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemiaR.M. Gilmore, Katie S. Gatwood, Karin Abernathy et al.|Bone Marrow Transplantation|2024Cited by 2
Efficacy and Safety of a Novel Non-Myeloablative Conditioning Regimen for Hematopoietic Cell Transplantation in Adults with Severe Aplastic AnemiaR.M. Gilmore, Katie S. Gatwood, Karin Abernathy et al.|Blood|2022Cited by 1